Shares of the company are trading at $223.43 much higher than $202.61, the stock’s 50 day moving average and which is well above the 200 day moving average of $200.42. The 50 day moving average was up $20.82 or +10.27% and the 200 day average moved up $23.01. 121K shares changed hands by the end of trading on Tuesday. Overall, volume was up 48.17% over the stocks normal daily volume.
Short traders are feeling a little more bullish on shares of the company of late if you take a look at the decrease in short interest. The company recorded a fall in short interest of -0.38% between September 29, 2017 and October 13, 2017. Short shares decreased from 1,532,761 to 1,526,945 over that timeframe. With short interest at 1,526,945 and short average daily volume at 71,415, days to cover is 21.0 and the short interest percentage is 0.10% as of October 13.
There has been some selling insider activity on Chemed Corp (NYSE:CHE) recently. Patrick P. Grace, Director let go of $100,740 worth of shares at an average price of $201.48 on October 2nd. That brings the Director’s holdings to $909,682 as reported to the SEC.
These funds have shifted positions in (CHE). Bbva Compass Bancshares, Inc reduced its stake by selling 16 shares a decrease of 27.6% in the quarter. Bbva Compass Bancshares, Inc controls 42 shares with a value of $8,000. The value of the position overall is down by 33.3%. As of the end of the quarter Parkside Financial Bank & Trust had disposed of 216 shares trimming its position 25.5%. The value of the company’s investment in Chemed Corp decreased from $173,000 to $127,000 decreasing 26.6% quarter over quarter.
As of quarter end Hanson & Doremus Investment Management had sold a total of 14 shares trimming its stake by 0.2%. The value of the investment in CHE went from $1,529,000 to $1,508,000 a change of $21,000 since the last quarter. Aperio Group, LLC divested its ownership by shedding 494 shares a decrease of 3.2% as of 09/30/2017. Aperio Group, LLC claims 15,051 shares valued at $3,041,000. The total value of its holdings decreased 4.3%.
KeyBanc began coverage of CHE by announcing an initial rating of “Sector Weight”. October 27 investment analysts at Oppenheimer maintained a company rating of “Outperform” but moved up the price target from $150.00 to $225.00.
The company is up by 0.35% since yesterday’s close of $223.43. Additionally the company announced a dividend paid on Friday September 1st, 2017. The dividend was $0.280 per share for the quarter which is $1.12 annualized. This dividend amount represented a yield of $0.48. The ex-dividend date was set for Thursday the 10th of August 2017.
The company’s P/E ratio is 55.43 and the market value is 3.57B. As of the last earnings report the EPS was $4.03 and is estimated to be $8.33 for the current year with 15,991,000 shares now outstanding. Analysts expect next quarter’s EPS will be $1.98 and the next full year EPS is anticipated to be $8.84.
Chemed Corporation, launched on April 2, 1970, purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter)..